- Isotype:
- recombinant human IgG1
- Applications:
- FC
Related products for CD19 CAR Detection Reagent, human
CD19 CAR+ T cells, generated using the CliniMACS ProdigyR TCT process within 12 days, were stained with CD19 CAR Detection Reagent, Biotin Antibody-PE, CD3-FITC, and 7-AAD Staining Solution and analyzed by flow cytometry using the MACSQuant® Analyzer 10. Cell debris and dead cells were excluded from the analysis based on scatter signals and 7-AAD fluorescence. Shown are viable CD3+ T cells.
The CD19 CAR Detection Reagent, anti-human, Biotin, REAfinity™ has been developed for the detection of transduced T cells that are engineered to express CD19-specific chimeric antigen receptors (CAR) on the cell surface, which recognize human CD19 antigen.
The CD19 CAR Detection Reagent is an antigen based detection reagent conjugated to biotin. It contains a recombinantly expressed fusion protein consisting of the human CD19 extracellular domains and a specifically mutated human IgG1 Fc region.
The engineered CD19 CAR T cells can be detected via the recognition of the CD19 protein, and identified by flow cytometry via anti-biotin fluorochromes. The mutated human IgG1 Fc region of the CD19 CAR Detection Reagent abolishes their binding to Fcγ receptors. This allows for background-free analysis and eliminates the need for additional blocking steps, such as using a FcR blocking reagent.
CD19 antigen, CD19 protein
Technical specifications
To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.
Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.
You have previously chosen International as your location.
What do you want to do?